Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day
    • BeatO raises Rs 8.45...

    BeatO raises Rs 8.45 crore from Leo Capital, Blume Ventures

    Written by Ruby Khatun Khatun Published On 2018-04-06T10:00:07+05:30  |  Updated On 6 April 2018 10:00 AM IST
    BeatO raises Rs 8.45 crore from Leo Capital, Blume Ventures

    New Delhi: BeatO, a startup for diabetic patients, has raised an institutional funding of USD 1.3 million (Rs 8.45 crore), led by Leo Capital and co-led by Blume Ventures.


    BeatO offers a smartphone-based glucometer. Started just over 2 years ago, BeatO currently serves 25,000 active customers in more than 1,500 cities.


    The company said it is currently fulfilling over 5,000 transactions a month.


    "India is expected to have 100 million diabetics by 2030. This puts tremendous pressure on all stakeholders in the healthcare eco-system both from a cost and well-being perspective to specially cater to this large demographic," BeatO co-founder and CEO Gautam Chopra said in a statement.


    With this funding, BeatO plans to strengthen its technology and distribution.


    "We will also supplement our existing range of product categories including diabetic snacks and specialty foods," the company said.


    BeatO had previously raised an angel round from a few individual investors including Rajeev Chitrabhanu (an early investor in Nazara Technologies) and Vishal Sampat (angel investor).


    The statement said BeatO has grown 10 times in revenue within the last one year.

    angel investorBeatOBlume Venturesdiabetic patientsfundFund raisefund raisingfundingGautam ChopraglucometerLeo CapitalNazara TechnologiesRaisesRajeev ChitrabhanusmartphonestartupVishal Sampat
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok